Loading…

Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center

Legionnaires' disease (LD) can be fatal among high‐risk transplant recipients. To understand the epidemiology of LD, we reviewed 15‐year longitudinal data from a center in Seattle, Washington that cares for both solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. We...

Full description

Saved in:
Bibliographic Details
Published in:Transplant infectious disease 2017-10, Vol.19 (5), p.n/a
Main Authors: Sivagnanam, Shobini, Podczervinski, Sara, Butler‐Wu, Susan M., Hawkins, Vivian, Stednick, Zach, Helbert, Lois A., Glover, William A., Whimbey, Estella, Duchin, Jeffrey, Cheng, Guang‐Shing, Pergam, Steven A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513
cites cdi_FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513
container_end_page n/a
container_issue 5
container_start_page
container_title Transplant infectious disease
container_volume 19
creator Sivagnanam, Shobini
Podczervinski, Sara
Butler‐Wu, Susan M.
Hawkins, Vivian
Stednick, Zach
Helbert, Lois A.
Glover, William A.
Whimbey, Estella
Duchin, Jeffrey
Cheng, Guang‐Shing
Pergam, Steven A.
description Legionnaires' disease (LD) can be fatal among high‐risk transplant recipients. To understand the epidemiology of LD, we reviewed 15‐year longitudinal data from a center in Seattle, Washington that cares for both solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. We identified all laboratory‐confirmed LD and extracted data on species, diagnostic modalities, clinical presentation, management, and outcomes from medical records. Among 32 patients with LD, transplant recipients made up the majority of diagnoses (22, 69%; SOT 10, HCT 12). Approximately 0.8% of transplant recipients who underwent Legionella‐specific testing were positive. Non‐pneumophila Legionella species (LNLP), which are not detected by urinary antigen test, accounted for half the cases, led by Legionella micdadei (32%). The severity and outcome between Legionella pneumophila and LNLP infections were similar (attributed mortality, 36% vs 27%); all LNLP deaths occurred in transplant recipients with L. micdadei. The clinical and radiological features mimicked other opportunistic pathogens; 32% (n=7) were not on empiric treatment at the time of diagnosis. These data add to the emerging literature describing the importance of LD and highlight the need for both routine Legionella testing on transplant recipients with pulmonary findings and empiric Legionella‐active antibiotic therapy.
doi_str_mv 10.1111/tid.12745
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1917961756</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1946999942</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513</originalsourceid><addsrcrecordid>eNp1kc1O3DAUhS1U1KG0C16gstQFZRGwHcc_3SEKBWkkNtN15IlvkEeZJLUdqtnxCH1GnqQXZmCBxNnYsr575HMPIUecnXLUWQ7-lAstqz1ywEtri5Ip8eH5bgohdDkjn1JaMca1lfYjmQmjrGJaH5D1HO7C0PcuREjH1IcELgENPc3R9WnsXJ9phCaMAfqcftBzyqvHh38bcBHfcxzSCE0O90BTnvzmadLRDDEHFzdItBCj62iD0xA_k_3WdQm-7M5D8vvqcnFxXcxvf91cnM-LRnJbFaVhy6X1DOX8UnFjjOdtBQqEsUI4JhqpQRsQ1shKiLYsW6akVdp56SteHpLvW98xDn8mSLleh9RAh2lgmFLNLW5CcV0pRL-9QVfDFHv8HVJSWZQUSJ1sqQYDJ0xVjzGsMWHNWf3UQY0d1M8dIPt15zgt1-BfyZelI3C2Bf6GDjbvO9WLm59by__sqpC5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1946999942</pqid></control><display><type>article</type><title>Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center</title><source>Wiley</source><creator>Sivagnanam, Shobini ; Podczervinski, Sara ; Butler‐Wu, Susan M. ; Hawkins, Vivian ; Stednick, Zach ; Helbert, Lois A. ; Glover, William A. ; Whimbey, Estella ; Duchin, Jeffrey ; Cheng, Guang‐Shing ; Pergam, Steven A.</creator><creatorcontrib>Sivagnanam, Shobini ; Podczervinski, Sara ; Butler‐Wu, Susan M. ; Hawkins, Vivian ; Stednick, Zach ; Helbert, Lois A. ; Glover, William A. ; Whimbey, Estella ; Duchin, Jeffrey ; Cheng, Guang‐Shing ; Pergam, Steven A.</creatorcontrib><description>Legionnaires' disease (LD) can be fatal among high‐risk transplant recipients. To understand the epidemiology of LD, we reviewed 15‐year longitudinal data from a center in Seattle, Washington that cares for both solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. We identified all laboratory‐confirmed LD and extracted data on species, diagnostic modalities, clinical presentation, management, and outcomes from medical records. Among 32 patients with LD, transplant recipients made up the majority of diagnoses (22, 69%; SOT 10, HCT 12). Approximately 0.8% of transplant recipients who underwent Legionella‐specific testing were positive. Non‐pneumophila Legionella species (LNLP), which are not detected by urinary antigen test, accounted for half the cases, led by Legionella micdadei (32%). The severity and outcome between Legionella pneumophila and LNLP infections were similar (attributed mortality, 36% vs 27%); all LNLP deaths occurred in transplant recipients with L. micdadei. The clinical and radiological features mimicked other opportunistic pathogens; 32% (n=7) were not on empiric treatment at the time of diagnosis. These data add to the emerging literature describing the importance of LD and highlight the need for both routine Legionella testing on transplant recipients with pulmonary findings and empiric Legionella‐active antibiotic therapy.</description><identifier>ISSN: 1398-2273</identifier><identifier>EISSN: 1399-3062</identifier><identifier>DOI: 10.1111/tid.12745</identifier><identifier>PMID: 28696077</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Aged ; Antibiotics ; Antigens, Bacterial - urine ; Diagnostic systems ; Epidemiology ; Female ; Health risk assessment ; Hematopoietic Stem Cell Transplantation - adverse effects ; Humans ; immunocompromised ; Legionella ; Legionella - isolation &amp; purification ; Legionella micdadei ; Legionnaires disease ; Legionnaires' Disease - complications ; Legionnaires' Disease - epidemiology ; Legionnaires' disease bacterium ; Lung transplantation ; Male ; Medical records ; Middle Aged ; Opportunist infection ; Organ Transplantation - adverse effects ; pneumonia ; Retrospective Studies ; Tertiary Care Centers ; Time Factors ; transplantation ; Washington - epidemiology</subject><ispartof>Transplant infectious disease, 2017-10, Vol.19 (5), p.n/a</ispartof><rights>2017 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd</rights><rights>2017 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><rights>2017 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513</citedby><cites>FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513</cites><orcidid>0000-0003-1028-7087</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Ftid.12745$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Ftid.12745$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,786,790,27957,27958,50923,51032</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28696077$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sivagnanam, Shobini</creatorcontrib><creatorcontrib>Podczervinski, Sara</creatorcontrib><creatorcontrib>Butler‐Wu, Susan M.</creatorcontrib><creatorcontrib>Hawkins, Vivian</creatorcontrib><creatorcontrib>Stednick, Zach</creatorcontrib><creatorcontrib>Helbert, Lois A.</creatorcontrib><creatorcontrib>Glover, William A.</creatorcontrib><creatorcontrib>Whimbey, Estella</creatorcontrib><creatorcontrib>Duchin, Jeffrey</creatorcontrib><creatorcontrib>Cheng, Guang‐Shing</creatorcontrib><creatorcontrib>Pergam, Steven A.</creatorcontrib><title>Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center</title><title>Transplant infectious disease</title><addtitle>Transpl Infect Dis</addtitle><description>Legionnaires' disease (LD) can be fatal among high‐risk transplant recipients. To understand the epidemiology of LD, we reviewed 15‐year longitudinal data from a center in Seattle, Washington that cares for both solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. We identified all laboratory‐confirmed LD and extracted data on species, diagnostic modalities, clinical presentation, management, and outcomes from medical records. Among 32 patients with LD, transplant recipients made up the majority of diagnoses (22, 69%; SOT 10, HCT 12). Approximately 0.8% of transplant recipients who underwent Legionella‐specific testing were positive. Non‐pneumophila Legionella species (LNLP), which are not detected by urinary antigen test, accounted for half the cases, led by Legionella micdadei (32%). The severity and outcome between Legionella pneumophila and LNLP infections were similar (attributed mortality, 36% vs 27%); all LNLP deaths occurred in transplant recipients with L. micdadei. The clinical and radiological features mimicked other opportunistic pathogens; 32% (n=7) were not on empiric treatment at the time of diagnosis. These data add to the emerging literature describing the importance of LD and highlight the need for both routine Legionella testing on transplant recipients with pulmonary findings and empiric Legionella‐active antibiotic therapy.</description><subject>Aged</subject><subject>Antibiotics</subject><subject>Antigens, Bacterial - urine</subject><subject>Diagnostic systems</subject><subject>Epidemiology</subject><subject>Female</subject><subject>Health risk assessment</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Humans</subject><subject>immunocompromised</subject><subject>Legionella</subject><subject>Legionella - isolation &amp; purification</subject><subject>Legionella micdadei</subject><subject>Legionnaires disease</subject><subject>Legionnaires' Disease - complications</subject><subject>Legionnaires' Disease - epidemiology</subject><subject>Legionnaires' disease bacterium</subject><subject>Lung transplantation</subject><subject>Male</subject><subject>Medical records</subject><subject>Middle Aged</subject><subject>Opportunist infection</subject><subject>Organ Transplantation - adverse effects</subject><subject>pneumonia</subject><subject>Retrospective Studies</subject><subject>Tertiary Care Centers</subject><subject>Time Factors</subject><subject>transplantation</subject><subject>Washington - epidemiology</subject><issn>1398-2273</issn><issn>1399-3062</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kc1O3DAUhS1U1KG0C16gstQFZRGwHcc_3SEKBWkkNtN15IlvkEeZJLUdqtnxCH1GnqQXZmCBxNnYsr575HMPIUecnXLUWQ7-lAstqz1ywEtri5Ip8eH5bgohdDkjn1JaMca1lfYjmQmjrGJaH5D1HO7C0PcuREjH1IcELgENPc3R9WnsXJ9phCaMAfqcftBzyqvHh38bcBHfcxzSCE0O90BTnvzmadLRDDEHFzdItBCj62iD0xA_k_3WdQm-7M5D8vvqcnFxXcxvf91cnM-LRnJbFaVhy6X1DOX8UnFjjOdtBQqEsUI4JhqpQRsQ1shKiLYsW6akVdp56SteHpLvW98xDn8mSLleh9RAh2lgmFLNLW5CcV0pRL-9QVfDFHv8HVJSWZQUSJ1sqQYDJ0xVjzGsMWHNWf3UQY0d1M8dIPt15zgt1-BfyZelI3C2Bf6GDjbvO9WLm59by__sqpC5</recordid><startdate>201710</startdate><enddate>201710</enddate><creator>Sivagnanam, Shobini</creator><creator>Podczervinski, Sara</creator><creator>Butler‐Wu, Susan M.</creator><creator>Hawkins, Vivian</creator><creator>Stednick, Zach</creator><creator>Helbert, Lois A.</creator><creator>Glover, William A.</creator><creator>Whimbey, Estella</creator><creator>Duchin, Jeffrey</creator><creator>Cheng, Guang‐Shing</creator><creator>Pergam, Steven A.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1028-7087</orcidid></search><sort><creationdate>201710</creationdate><title>Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center</title><author>Sivagnanam, Shobini ; Podczervinski, Sara ; Butler‐Wu, Susan M. ; Hawkins, Vivian ; Stednick, Zach ; Helbert, Lois A. ; Glover, William A. ; Whimbey, Estella ; Duchin, Jeffrey ; Cheng, Guang‐Shing ; Pergam, Steven A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Antibiotics</topic><topic>Antigens, Bacterial - urine</topic><topic>Diagnostic systems</topic><topic>Epidemiology</topic><topic>Female</topic><topic>Health risk assessment</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Humans</topic><topic>immunocompromised</topic><topic>Legionella</topic><topic>Legionella - isolation &amp; purification</topic><topic>Legionella micdadei</topic><topic>Legionnaires disease</topic><topic>Legionnaires' Disease - complications</topic><topic>Legionnaires' Disease - epidemiology</topic><topic>Legionnaires' disease bacterium</topic><topic>Lung transplantation</topic><topic>Male</topic><topic>Medical records</topic><topic>Middle Aged</topic><topic>Opportunist infection</topic><topic>Organ Transplantation - adverse effects</topic><topic>pneumonia</topic><topic>Retrospective Studies</topic><topic>Tertiary Care Centers</topic><topic>Time Factors</topic><topic>transplantation</topic><topic>Washington - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sivagnanam, Shobini</creatorcontrib><creatorcontrib>Podczervinski, Sara</creatorcontrib><creatorcontrib>Butler‐Wu, Susan M.</creatorcontrib><creatorcontrib>Hawkins, Vivian</creatorcontrib><creatorcontrib>Stednick, Zach</creatorcontrib><creatorcontrib>Helbert, Lois A.</creatorcontrib><creatorcontrib>Glover, William A.</creatorcontrib><creatorcontrib>Whimbey, Estella</creatorcontrib><creatorcontrib>Duchin, Jeffrey</creatorcontrib><creatorcontrib>Cheng, Guang‐Shing</creatorcontrib><creatorcontrib>Pergam, Steven A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Transplant infectious disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sivagnanam, Shobini</au><au>Podczervinski, Sara</au><au>Butler‐Wu, Susan M.</au><au>Hawkins, Vivian</au><au>Stednick, Zach</au><au>Helbert, Lois A.</au><au>Glover, William A.</au><au>Whimbey, Estella</au><au>Duchin, Jeffrey</au><au>Cheng, Guang‐Shing</au><au>Pergam, Steven A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center</atitle><jtitle>Transplant infectious disease</jtitle><addtitle>Transpl Infect Dis</addtitle><date>2017-10</date><risdate>2017</risdate><volume>19</volume><issue>5</issue><epage>n/a</epage><issn>1398-2273</issn><eissn>1399-3062</eissn><notes>Funding information</notes><notes>This work was supported by the Joseph Thornton Tweddle Research Entry Scholarship through the Royal Australasian College of Physicians Foundation to S.S.</notes><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Legionnaires' disease (LD) can be fatal among high‐risk transplant recipients. To understand the epidemiology of LD, we reviewed 15‐year longitudinal data from a center in Seattle, Washington that cares for both solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients. We identified all laboratory‐confirmed LD and extracted data on species, diagnostic modalities, clinical presentation, management, and outcomes from medical records. Among 32 patients with LD, transplant recipients made up the majority of diagnoses (22, 69%; SOT 10, HCT 12). Approximately 0.8% of transplant recipients who underwent Legionella‐specific testing were positive. Non‐pneumophila Legionella species (LNLP), which are not detected by urinary antigen test, accounted for half the cases, led by Legionella micdadei (32%). The severity and outcome between Legionella pneumophila and LNLP infections were similar (attributed mortality, 36% vs 27%); all LNLP deaths occurred in transplant recipients with L. micdadei. The clinical and radiological features mimicked other opportunistic pathogens; 32% (n=7) were not on empiric treatment at the time of diagnosis. These data add to the emerging literature describing the importance of LD and highlight the need for both routine Legionella testing on transplant recipients with pulmonary findings and empiric Legionella‐active antibiotic therapy.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28696077</pmid><doi>10.1111/tid.12745</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-1028-7087</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1398-2273
ispartof Transplant infectious disease, 2017-10, Vol.19 (5), p.n/a
issn 1398-2273
1399-3062
language eng
recordid cdi_proquest_miscellaneous_1917961756
source Wiley
subjects Aged
Antibiotics
Antigens, Bacterial - urine
Diagnostic systems
Epidemiology
Female
Health risk assessment
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
immunocompromised
Legionella
Legionella - isolation & purification
Legionella micdadei
Legionnaires disease
Legionnaires' Disease - complications
Legionnaires' Disease - epidemiology
Legionnaires' disease bacterium
Lung transplantation
Male
Medical records
Middle Aged
Opportunist infection
Organ Transplantation - adverse effects
pneumonia
Retrospective Studies
Tertiary Care Centers
Time Factors
transplantation
Washington - epidemiology
title Legionnaires' disease in transplant recipients: A 15‐year retrospective study in a tertiary referral center
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T10%3A20%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Legionnaires'%20disease%20in%20transplant%20recipients:%20A%2015%E2%80%90year%20retrospective%20study%20in%20a%20tertiary%20referral%20center&rft.jtitle=Transplant%20infectious%20disease&rft.au=Sivagnanam,%20Shobini&rft.date=2017-10&rft.volume=19&rft.issue=5&rft.epage=n/a&rft.issn=1398-2273&rft.eissn=1399-3062&rft_id=info:doi/10.1111/tid.12745&rft_dat=%3Cproquest_cross%3E1946999942%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4195-380bb9d0000adb61888d1f5e6e28922a02c47e78e2984522f33f064967ad4d513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1946999942&rft_id=info:pmid/28696077&rfr_iscdi=true